MiniMed™ 780G from Medtronic is an advanced next generation closed loop insulin pump system for the treatment of diabetes in people age 7 to 80 years. Leveraging the most advanced SmartGuard™ algorithm, adapted from DreaMed's Glucositter, the system automates the delivery of both basal insulin and correction boluses every five minutes to aid people with diabetes avoid highs and lows with greater ease. The MiniMed 780G system enables the personalisation of glucose goals with an adjustable target setting as low as 100 mg/dL. With the addition of Bluetooth® connectivity, the MiniMed 780G system will enable users and their care partners to view real-time glucose data and trends on compatible iOS and Android smartphones via apps. The system now has CE Mark approval as well.